Nu-Med Plus (NUMD) EPS (Basic) (QoQ) (2013 - 2025)
Nu-Med Plus (NUMD) EPS (Basic) (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.45% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 41.48% |
| Mar 31, 2025 | -88.85% |
| Dec 31, 2024 | 44.97% |
| Sep 30, 2024 | -8.04% |
| Jun 30, 2024 | 18.65% |
| Mar 31, 2024 | 62.30% |
| Dec 31, 2023 | -243.60% |
| Sep 30, 2023 | 32.54% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | -165.06% |
| Dec 31, 2022 | 173.20% |
| Sep 30, 2022 | 0.52% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 97.48% |
| Dec 31, 2021 | -1,896.62% |
| Sep 30, 2021 | 51.21% |
| Jun 30, 2021 | 32.06% |
| Mar 31, 2021 | 51.68% |